BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of conformationally-constrained MMP inhibitors. 1998

M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA.

A novel series of conformationally constrained matrix metalloprotease inhibitors was identified. The potencies observed for these inhibitors were highly dependent upon the substitution pattern on the caprolactam ring as well as the succinate moiety.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002209 Caprolactam Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation. Aminocaproic Lactam,Hexahydro-2H-Azepin-2-One,Hexahydro 2H Azepin 2 One,Lactam, Aminocaproic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013386 Succinates Derivatives of SUCCINIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,4-carboxy terminated aliphatic structure. Succinic Acids,Acids, Succinic

Related Publications

M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Synthesis and identification of conformationally constrained selective MMP inhibitors.
July 1999, Bioorganic & medicinal chemistry letters,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptase.
November 2011, Journal of medicinal chemistry,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design, synthesis, and biological evaluation of conformationally constrained cis-amide Hsp90 inhibitors.
June 2009, Organic letters,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
December 1998, Bioorganic & medicinal chemistry,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR.
October 2013, ACS medicinal chemistry letters,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Sulfonamide-based acyclic and conformationally constrained MMP inhibitors: from computer-assisted design to nanomolar compounds.
January 2004, Current topics in medicinal chemistry,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design and synthesis of conformationally constrained salinomycin derivatives.
September 2017, European journal of medicinal chemistry,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design and synthesis of conformationally constrained glucagon analogues.
May 2000, Journal of medicinal chemistry,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design of conformationally constrained angiotensin-converting enzyme inhibitors.
November 1984, Biochemical and biophysical research communications,
M G Natchus, and M Cheng, and C T Wahl, and S Pikul, and N G Almstead, and R S Bradley, and Y O Taiwo, and G E Mieling, and C M Dunaway, and C E Snider, and J M McIver, and B L Barnett, and S J McPhail, and M B Anastasio, and B De
Design, synthesis, and biological evaluation of conformationally constrained glycerol 3-phosphate acyltransferase inhibitors.
September 2010, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!